The MHRA Quality of Medicines - Future Evolution conference is principally aimed at individuals working for independent Good Manufacturing Practice Quality Control (GMP QC) laboratories contracted to conduct release testing of medicinal products, intermediates or active pharmaceutical ingredients and others in this industry sector.
The conference will focus on industry and regulatory viewpoints concerning current manufacturing quality control and pharmacopoeial practices. It will provide a unique platform for cross-collaboration and discussion between Industry, International Pharmacopoeia Authorities and International Regulators. A number of hot topics will be covered at the event and will include for example, Good Pharmacopoeial Practices and potential challenges working in a GMP QC laboratory (such as out of specifications and data integrity) and the latest technological developments in pharmaceutical world (such as Biologicals / Biosimilars, Quality by Design (QbD) or Harmonisation).
The conference will focus on industry and regulatory viewpoints concerning current manufacturing quality control and pharmacopoeial practices. It will provide a unique platform for cross-collaboration and discussion between Industry, International Pharmacopoeia Authorities and International Regulators. A number of hot topics will be covered at the event and will include for example, Good Pharmacopoeial Practices and potential challenges working in a GMP QC laboratory (such as out of specifications and data integrity) and the latest technological developments in pharmaceutical world (such as Biologicals / Biosimilars, Quality by Design (QbD) or Harmonisation).
